Surgical Sutures Market Analysis and Forecast to 2031: By Type (Absorbable, Non-absorbable), By Filament (Monofilament, Multifilament), By Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery) and Region

Surgical Sutures Market Analysis and Forecast to 2031: By Type (Absorbable, Non-absorbable), By Filament (Monofilament, Multifilament), By Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery) and Region

The global surgical sutures market was valued at USD 4.3 billion in 2021 and it is anticipated to grow up to USD 5.6 billion by 2031, at a CAGR of 2.6% during the forecast period.

Surgical suture is one of the most common medical devices used by doctors during surgeries. The suture helps in holding body tissues together after a surgery or an injury. The application of a suture essentially involves the use of a needle along with an attached thread. Surgical sutures are used to close wounds such as skin ulcers, neuropathic ulcers, pediatric cardiac surgery, and diabetic ulcers. These sutures cause less reaction and provide better passage of the thread through the tissue.

Market Trends and Drivers

Increasing number of surgical procedures will augment the market growth. According to the WHO 2016 Report, the estimated mean global surgical rate was 4,469 operations per 100,000 people per year, with road accidents and associated trauma being the major cause of surgical treatment. According to the EC Factsheet 2017, globally, there are around 174 fatalities per million population every year. Furthermore, WHO data estimates that around 1.3 million people die each year on the roads. For every road accident-related death, there are 20 other persons who sustain non-fatal injuries that often require surgical intervention. The aging population is at a higher risk of chronic diseases and conditions and requires frequent surgeries. Adults aged 65 and above account for a large fraction of surgeries performed in the US. The rapid growth in the aging population and the growing incidence of various chronic diseases are expected to significantly drive the number of surgeries performed globally.

Furthermore, by 2030, non-communicable diseases (NCDs) are projected to account for more than one-half of the disease burden in low-income countries and more than three-fourths in middle-income countries. In the geriatric population, NCDs account for more than 87% of the burden in low, middle, and high-income countries. The high prevalence of chronic diseases, especially among the geriatric population, will considerably boost the number of surgical treatment procedures conducted and thus drive the demand and use of surgical sutures.

Market Restraints and Challenges

Presence of alternative wound care management products may hamper the market growth. Topical skin adhesives, hemostatic and sealing agents (such as fibrin sealants, surgical sealants, gelatin-based sealants, human fibrinogen, and thrombin fleeces), and wound closure devices (such as stapling devices, ligating clips, and wound closure strips) are some alternatives to surgical sutures. These alternative products are associated with certain advantages. For instance, stapling is quicker than suturing. Furthermore, the area requiring suturing is an important factor for determining the selection of material. In the case of head injuries, a stapler can work quickly, saving time and blood loss, thus making it a preferred choice over sutures. Similarly, small incisions and wounds (less than 10 cm) can be closed by tissue adhesives in a relatively painless procedure for pediatric patients without the need for removal, as in the case of sutures. Wound closure strips and tapes can also be used to close smaller lacerations. These products provide better closure and prognosis in the case of elderly patients, especially those with frail skin. Due to their efficiency and benefits over surgical sutures, the availability of alternatives is a key restraint for surgical suture market.

Global Surgical Sutures Market Segmental Overview

The report analyses the global  sutures market based on type, filament, application, and region.

Global Surgical Sutures Market by Type

Based on type, it is segmented into the absorbable and non-absorbable. The absorbable segment held the largest revenue share in 2021 owing to its ability to provide temporary support to wounds till it heals and can withstand normal stress. Moreover, the demand for absorbable sutures is continuously rising, which can be attributed to their ability to degrade naturally. Due to this, key players in the market are investing in RD activities, which is further expected to help the absorbable segment grow in the future.

Global Surgical Sutures Market by Filament

Based on filament, it is segmented into monofilament and multifilament. The multifilament segment dominated the market for surgical sutures with a significant revenue size in 2021. The multifilament segment is also expected to witness the fastest growth during the forecast period. This can be attributed to advantages associated with the multifilament segment such as better pliability, high tensile strength, and flexibility.

Global Surgical Sutures Market by Application

Based on application, it is segmented into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurological surgery and others. The cardiovascular surgery segment is likely to dominate the market during the forecast period. This is owing to the high incidence of cardiac diseases, the presence of sufficient experts in the field, supportive reimbursement scenarios, and advancement in diagnostics. This is leading to a significant rise in the number of cardiac surgeries, which in turn, is leading to an increase in the demand for surgical sutures over the forecast period.

Geographical Analysis of Global Surgical Sutures Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is accounted for the majority of market share during the forecast period. This is due to the owing to the presence of local and key players, high cost of sutures as compared to other regions, supportive reimbursement scenario, rising government programs, and developed healthcare infrastructure. Technological advancements and high domestic income are also the key factors that are contributing to the large revenue share of North America.

Major Players in the Global Surgical Sutures MarketCOVID-19 Impact

The COVID-19 outbreak, the medical devices market accounts for 60–75 percent of the market overall and includes products like imaging devices, dental care devices, and surgical products, to stagnate or experience a sharp decline in growth rate in 2020 and the first and second quarters of 2021. By 2021, the market for medical devices, which includes critical care medical equipment, will expand by USD 5-7 billion. Contrarily, compared to other medical equipment including those utilised in ICUs, CCUs, and emergency departments of hospitals, surgical consumables such as surgical sutures that are viewed as a part of that industry do not exhibit a significant revenue shift in 2020 and 2021. This is due to suture products are not in high demand during surgical procedures. Owing to the pandemic situation, surgical procedures have decreased and are only predicted to increase in the first quarter of 2021. This is anticipated to have a limited impact on the growth of the surgical suture market. The leading players in the surgical suture market have been compelled by the shift in demand toward medical devices to plan their manufacturing capacities, concentrate on new product development, and offer the best supply chain strategies targeted at COVID-19 necessities.

Recent Developments

• In August 2021, Ethicon US, LLC, part of Johnson Johnson, announced the launch of ProxiSure Suturing Device in the U.S. The device features Ethicon endomechanical, suture and curved needle technologies and is an advanced laparoscopic suturing device.
• In April 2021, Dolphin Sutures,a announced the expansion of its Dental product portfolio for the first time in India to launch non-absorbable Polytetrafluoroethylene sutures. The new TEFLENE product line includes dense PTFE.
• In September 2020, Smith Nephew (UK) launched NOVOSTITCH PRO Meniscal Repair System-an automated suturing device.
• In December 2019, AMS(UK) acquired Biomatlante,(France) a manufacturer of surgical biomaterial technologies, with the aim to strengthen the company’s product portfolio, RD pipeline, and market access.

Frequently Asked Questions

Q1. How big is the surgical sutures market?Ans. The global surgical sutures market size was USD 4.3 Billion in 2021 and is anticipated to reach USD 5.6 Billion in 2031, growing at a rate 2.6% from 2022 to 2031.Q2. What is the surgical sutures market growth rate?Ans. The growth rate of the surgical sutures market is 2.6%.Q3. Which region holds a major market share for the surgical sutures market?Ans. North America holds a major market share of the surgical sutures market in 2021.Q4. Which segment accounted for the largest surgical sutures market share?Ans. By end user, the hospitals segment accounted for the largest surgical sutures market share.Q5. Who are the key players in the surgical sutures market?Q6. What are the factors driving the surgical sutures market growth?Ans. The major factors driving the growth of the market are the rising demand for surgical suture due to the increasing number surgical procedure across the globe.Q7. What are the key growth strategies of surgical sutures market players?Ans. The key growth strategies of surgical sutures market players are product launch and product approval.Q8. Which region will provide more business opportunities for the surgical sutures market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the surgical sutures market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.